Escherichia Coli E Coli Diagnostic Testing Market

The global diagnostic testing market for escherichia coli (E. coli) was valued at US$ 1.3 billion in 2018 and is expected to reach a market value of about US$ 3.9 billion by 2030 growing at a CAGR of 11.5% over the forecast period. Also known as E, Escherichia coli. Coli is a bacterium that usually grows in animal and human intestines. E-Coli is regarded as an important part of a healthy intestinal system. Several other, however, are pathogenic in nature and may lead to diarrhoea and disease. E. Coli causing diarrhoea may be transmitted through contaminated food and water or through direct human or animal contact. The seller's landscape has become significantly fragmented in recent times, as new players enter the market regularly.

The three main strategies implemented by most players in global E. Coil market include extensive focus on developing better test methods, launching innovative technologies and regulating service costs. E. coli is generally found in polluted food, mainly soft cheese produced from milk, undercooked ground beef, raw juice and milk, raw vegetables and fruits such as sprouts, polluted water such as untreated water as well as faeces of pre-infected people. Furthermore, the E.coli bacterium is present on the surface of bodies of animals such as cows, sheep and goats. In the hospital and community environments, coli bacteria are usually grown. Anyone who spends substantial time in such spaces can easily acquire the bacterium. Uncleanness in these environments further increases the spread of the bacterium to mushrooms. The main cause of global E was therefore a lack of cleanliness and a general ignorance of maintaining hygiene. Market of coli tests. But the cost of E is high. There is a lack of health experts in numerous undeveloped and remote regions, thus curbing the growth of the market. However, a number of players undertake extensive research and innovation, which is expected to reduce the restrictions in some way.

The global E. coli market is segmented on the basis of technology, application and geography. Based on technology, the global E. coli market is segmented into monoclonal antibodies, molecular diagnostics, differential light scattering, immunoassays, flow cytometry, gel micro-droplets, chromatography as well as diagnostic imaging among others. Based on application, the global E. coli market is sub-segmented into private labs, physician offices, hospitals, research institutes and public health labs. Geographically, the global E. coli market can be divided into North America, Europe, Asia Pacific, Middle East & Africa, and South America. Major players operating in the global E. coli market include Beckman Coulter, Abbott Laboratories, Becton, Wako, Affymetrix, Inc., Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux, Siemens AG, Thermo Fisher Scientific, Cepheid, Inc., F. Hoffmann-La Roche AG, Olympus Corporation, GenBio, Johnson & Johnson and Novartis among others.

Market Segmentation

By Technology

• monoclonal antibodies
• molecular diagnostics
• differential light scattering
• immunoassays
• flow cytometry
• gel micro-droplets
• chromatography
• diagnostic imaging

By Application

• private labs
• physician offices
• hospitals
• research institutes
• public health labs

By Geography

• North America
• Europe
• Asia Pacific
• Middle East & Africa
• South America